{
  "fullName": "Napoleone Ferrara",
  "slug": "napoleone-ferrara",
  "title": "MD",
  "specialty": "Anti-VEGF Oncology",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 200,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Napoleone Ferrara is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a career in Northern California at the biotechnology giant Genentech, where he pioneered the development of new treatments for angiogenic diseases such as cancer, age-related macular degeneration (AMD), and diabetic retinopathy. At Genentech, he discovered VEGF—and made the first anti-VEGF antibody—which suppresses growth of a variety of tumors. These findings helped lead to development and FDA approval of the first clinically effective angiogenesis inhibitor, bevacizumab (Avastin), which prevents the growth of new blood vessels into a solid tumor. Bevacizumab, first approved for treatment of metastatic colorectal cancer in 2004, has become part of standard treatment for a variety of cancers. Ferrara's work led also to the development of ranibizumab (Lucentis), a drug that is highly effective at preventing vision loss in patients with intraocular neovascular disorders such as neovascular AMD and retinal vein occlusion. Ranibizumab and other anti-VEGF agents represent the first effective therapy for such blinding disorders and rank among the most widely used drugs in older adults.",
  "aiSummary": "Napoleone Ferrara is a anti-vegf oncology specialist with an H-index of 200 at UC San Diego (Faculty). Has been published in Nature Medicine, Science, New England Journal of Medicine. Based in United States.",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/c/c1/Laura_Perin%2C_Napoleone_Ferrara%2C_and_Matteo_Garbelotto.jpg",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "UC San Diego",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Anti-VEGF Oncology"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "The biology of VEGF and its receptors",
      "journal": "Nature Medicine",
      "year": 2003,
      "citationCount": 9482,
      "doi": "10.1038/nm0603-669",
      "sourceUrl": "https://doi.org/10.1038/nm0603-669",
      "verified": true
    },
    {
      "title": "Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen",
      "journal": "Science",
      "year": 1989,
      "citationCount": 4996,
      "doi": "10.1126/science.2479986",
      "sourceUrl": "https://doi.org/10.1126/science.2479986",
      "verified": true
    },
    {
      "title": "The Biology of Vascular Endothelial Growth Factor",
      "journal": "Endocrine Reviews",
      "year": 1997,
      "citationCount": 4349,
      "doi": "10.1210/edrv.18.1.0287",
      "sourceUrl": "https://doi.org/10.1210/edrv.18.1.0287",
      "verified": true
    },
    {
      "title": "Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders",
      "journal": "New England Journal of Medicine",
      "year": 1994,
      "citationCount": 3755,
      "doi": "10.1056/nejm199412013312203",
      "sourceUrl": "https://doi.org/10.1056/nejm199412013312203",
      "verified": true
    },
    {
      "title": "Vascular Endothelial Growth Factor: Basic Science and Clinical Progress",
      "journal": "Endocrine Reviews",
      "year": 2004,
      "citationCount": 3653,
      "doi": "10.1210/er.2003-0027",
      "sourceUrl": "https://doi.org/10.1210/er.2003-0027",
      "verified": true
    },
    {
      "title": "Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo",
      "journal": "Nature",
      "year": 1993,
      "citationCount": 3594,
      "doi": "10.1038/362841a0",
      "sourceUrl": "https://doi.org/10.1038/362841a0",
      "verified": true
    },
    {
      "title": "Angiogenesis as a therapeutic target",
      "journal": "Nature",
      "year": 2005,
      "citationCount": 2615,
      "doi": "10.1038/nature04483",
      "sourceUrl": "https://doi.org/10.1038/nature04483",
      "verified": true
    },
    {
      "title": "VEGF in Signaling and Disease: Beyond Discovery and Development",
      "journal": "Cell",
      "year": 2019,
      "citationCount": 2574,
      "doi": "10.1016/j.cell.2019.01.021",
      "sourceUrl": "https://doi.org/10.1016/j.cell.2019.01.021",
      "verified": true
    },
    {
      "title": "Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer",
      "journal": "Nature Reviews Drug Discovery",
      "year": 2004,
      "citationCount": 2565,
      "doi": "10.1038/nrd1381",
      "sourceUrl": "https://doi.org/10.1038/nrd1381",
      "verified": true
    },
    {
      "title": "Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells",
      "journal": "Biochemical and Biophysical Research Communications",
      "year": 1989,
      "citationCount": 2260,
      "doi": "10.1016/0006-291x(89)92678-8",
      "sourceUrl": "https://doi.org/10.1016/0006-291x(89)92678-8",
      "verified": true
    },
    {
      "title": "The <i>fms</i> -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor",
      "journal": "Science",
      "year": 1992,
      "citationCount": 2030,
      "doi": "10.1126/science.1312256",
      "sourceUrl": "https://doi.org/10.1126/science.1312256",
      "verified": true
    },
    {
      "title": "HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation",
      "journal": "Cell",
      "year": 2003,
      "citationCount": 1993,
      "doi": "10.1016/s0092-8674(03)00154-5",
      "sourceUrl": "https://doi.org/10.1016/s0092-8674(03)00154-5",
      "verified": true
    },
    {
      "title": "Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway",
      "journal": "Journal of Biological Chemistry",
      "year": 1998,
      "citationCount": 1978,
      "doi": "10.1074/jbc.273.46.30336",
      "sourceUrl": "https://doi.org/10.1074/jbc.273.46.30336",
      "verified": true
    },
    {
      "title": "Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.",
      "journal": "PubMed",
      "year": 1997,
      "citationCount": 1615,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2154200023",
      "verified": true
    },
    {
      "title": "Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins",
      "journal": "Endocrine Reviews",
      "year": 1992,
      "citationCount": 1615,
      "doi": "10.1210/edrv-13-1-18",
      "sourceUrl": "https://doi.org/10.1210/edrv-13-1-18",
      "verified": true
    },
    {
      "title": "VEGF and the quest for tumour angiogenesis factors",
      "journal": "Nature reviews. Cancer",
      "year": 2002,
      "citationCount": 1500,
      "doi": "10.1038/nrc909",
      "sourceUrl": "https://doi.org/10.1038/nrc909",
      "verified": true
    },
    {
      "title": "Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2002,
      "citationCount": 1393,
      "doi": "10.1073/pnas.152324099",
      "sourceUrl": "https://doi.org/10.1073/pnas.152324099",
      "verified": true
    },
    {
      "title": "The Vascular Endothelial Growth Factor Family: Identification of a Fourth Molecular Species and Characterization of Alternative Splicing of RNA",
      "journal": "Molecular Endocrinology",
      "year": 1991,
      "citationCount": 1368,
      "doi": "10.1210/mend-5-12-1806",
      "sourceUrl": "https://doi.org/10.1210/mend-5-12-1806",
      "verified": true
    },
    {
      "title": "Structural Characterization and Biological Functions of Fibroblast Growth Factor",
      "journal": "Endocrine Reviews",
      "year": 1987,
      "citationCount": 1281,
      "doi": "10.1210/edrv-8-2-95",
      "sourceUrl": "https://doi.org/10.1210/edrv-8-2-95",
      "verified": true
    },
    {
      "title": "Vascular Endothelial Growth Factor",
      "journal": "Arteriosclerosis Thrombosis and Vascular Biology",
      "year": 2009,
      "citationCount": 1271,
      "doi": "10.1161/atvbaha.108.179663",
      "sourceUrl": "https://doi.org/10.1161/atvbaha.108.179663",
      "verified": true
    },
    {
      "title": "Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 1995,
      "citationCount": 1263,
      "doi": "10.1073/pnas.92.23.10457",
      "sourceUrl": "https://doi.org/10.1073/pnas.92.23.10457",
      "verified": true
    },
    {
      "title": "The Biology of Vascular Endothelial Growth Factor",
      "journal": "Endocrine Reviews",
      "year": 1997,
      "citationCount": 1223,
      "doi": "10.1210/er.18.1.4",
      "sourceUrl": "https://doi.org/10.1210/er.18.1.4",
      "verified": true
    },
    {
      "title": "Molecular and biological properties of vascular endothelial growth factor",
      "journal": "Journal of Molecular Medicine",
      "year": 1999,
      "citationCount": 1156,
      "doi": "10.1007/s001099900019",
      "sourceUrl": "https://doi.org/10.1007/s001099900019",
      "verified": true
    },
    {
      "title": "Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.",
      "journal": "Journal of Biological Chemistry",
      "year": 1992,
      "citationCount": 1130,
      "doi": "10.1016/s0021-9258(18)35712-0",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(18)35712-0",
      "verified": true
    },
    {
      "title": "The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.",
      "journal": "Molecular Biology of the Cell",
      "year": 1993,
      "citationCount": 1110,
      "doi": "10.1091/mbc.4.12.1317",
      "sourceUrl": "https://doi.org/10.1091/mbc.4.12.1317",
      "verified": true
    },
    {
      "title": "Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.",
      "journal": "Journal of Biological Chemistry",
      "year": 1994,
      "citationCount": 1102,
      "doi": "10.1016/s0021-9258(18)47298-5",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(18)47298-5",
      "verified": true
    },
    {
      "title": "Role of vascular endothelial growth factor in regulation of physiological angiogenesis",
      "journal": "American Journal of Physiology-Cell Physiology",
      "year": 2001,
      "citationCount": 1089,
      "doi": "10.1152/ajpcell.2001.280.6.c1358",
      "sourceUrl": "https://doi.org/10.1152/ajpcell.2001.280.6.c1358",
      "verified": true
    },
    {
      "title": "Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.",
      "journal": "Journal of Clinical Investigation",
      "year": 1994,
      "citationCount": 1040,
      "doi": "10.1172/jci117018",
      "sourceUrl": "https://doi.org/10.1172/jci117018",
      "verified": true
    },
    {
      "title": "Autocrine VEGF Signaling Is Required for Vascular Homeostasis",
      "journal": "Cell",
      "year": 2007,
      "citationCount": 1031,
      "doi": "10.1016/j.cell.2007.06.054",
      "sourceUrl": "https://doi.org/10.1016/j.cell.2007.06.054",
      "verified": true
    },
    {
      "title": "Clinical applications of angiogenic growth factors and their inhibitors",
      "journal": "Nature Medicine",
      "year": 1999,
      "citationCount": 1009,
      "doi": "10.1038/70928",
      "sourceUrl": "https://doi.org/10.1038/70928",
      "verified": true
    },
    {
      "title": "Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells",
      "journal": "Journal of Biological Chemistry",
      "year": 1998,
      "citationCount": 988,
      "doi": "10.1074/jbc.273.21.13313",
      "sourceUrl": "https://doi.org/10.1074/jbc.273.21.13313",
      "verified": true
    },
    {
      "title": "Ten years of anti-vascular endothelial growth factor therapy",
      "journal": "Nature Reviews Drug Discovery",
      "year": 2016,
      "citationCount": 981,
      "doi": "10.1038/nrd.2015.17",
      "sourceUrl": "https://doi.org/10.1038/nrd.2015.17",
      "verified": true
    },
    {
      "title": "Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy",
      "journal": "Biochemical and Biophysical Research Communications",
      "year": 2005,
      "citationCount": 964,
      "doi": "10.1016/j.bbrc.2005.05.132",
      "sourceUrl": "https://doi.org/10.1016/j.bbrc.2005.05.132",
      "verified": true
    },
    {
      "title": "VEGF is required for growth and survival in neonatal mice",
      "journal": "Development",
      "year": 1999,
      "citationCount": 915,
      "doi": "10.1242/dev.126.6.1149",
      "sourceUrl": "https://doi.org/10.1242/dev.126.6.1149",
      "verified": true
    },
    {
      "title": "Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro",
      "journal": "Biochemical and Biophysical Research Communications",
      "year": 1992,
      "citationCount": 861,
      "doi": "10.1016/0006-291x(92)92277-5",
      "sourceUrl": "https://doi.org/10.1016/0006-291x(92)92277-5",
      "verified": true
    },
    {
      "title": "Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells",
      "journal": "Nature Biotechnology",
      "year": 2007,
      "citationCount": 837,
      "doi": "10.1038/nbt1323",
      "sourceUrl": "https://doi.org/10.1038/nbt1323",
      "verified": true
    },
    {
      "title": "DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION",
      "journal": "Retina",
      "year": 2006,
      "citationCount": 835,
      "doi": "10.1097/01.iae.0000242842.14624.e7",
      "sourceUrl": "https://doi.org/10.1097/01.iae.0000242842.14624.e7",
      "verified": true
    },
    {
      "title": "Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes",
      "journal": "Journal of Biological Chemistry",
      "year": 1997,
      "citationCount": 790,
      "doi": "10.1074/jbc.272.38.23659",
      "sourceUrl": "https://doi.org/10.1074/jbc.272.38.23659",
      "verified": true
    },
    {
      "title": "Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 1993,
      "citationCount": 759,
      "doi": "10.1073/pnas.90.16.7533",
      "sourceUrl": "https://doi.org/10.1073/pnas.90.16.7533",
      "verified": true
    },
    {
      "title": "Targeting the tumour vasculature: insights from physiological angiogenesis",
      "journal": "Nature reviews. Cancer",
      "year": 2010,
      "citationCount": 742,
      "doi": "10.1038/nrc2868",
      "sourceUrl": "https://doi.org/10.1038/nrc2868",
      "verified": true
    },
    {
      "title": "Developmental and Pathological Angiogenesis",
      "journal": "Annual Review of Cell and Developmental Biology",
      "year": 2011,
      "citationCount": 721,
      "doi": "10.1146/annurev-cellbio-092910-154002",
      "sourceUrl": "https://doi.org/10.1146/annurev-cellbio-092910-154002",
      "verified": true
    },
    {
      "title": "Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 1996,
      "citationCount": 719,
      "doi": "10.1073/pnas.93.25.14765",
      "sourceUrl": "https://doi.org/10.1073/pnas.93.25.14765",
      "verified": true
    },
    {
      "title": "Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease",
      "journal": "Journal of Clinical Investigation",
      "year": 2012,
      "citationCount": 712,
      "doi": "10.1172/jci60842",
      "sourceUrl": "https://doi.org/10.1172/jci60842",
      "verified": true
    },
    {
      "title": "VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism",
      "journal": "Nature",
      "year": 2002,
      "citationCount": 704,
      "doi": "10.1038/nature00821",
      "sourceUrl": "https://doi.org/10.1038/nature00821",
      "verified": true
    },
    {
      "title": "Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.",
      "journal": "Journal of Clinical Investigation",
      "year": 1995,
      "citationCount": 698,
      "doi": "10.1172/jci117857",
      "sourceUrl": "https://doi.org/10.1172/jci117857",
      "verified": true
    },
    {
      "title": "Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.",
      "journal": "Journal of Biological Chemistry",
      "year": 1994,
      "citationCount": 692,
      "doi": "10.1016/s0021-9258(17)37365-9",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(17)37365-9",
      "verified": true
    },
    {
      "title": "Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.",
      "journal": "PubMed",
      "year": 2000,
      "citationCount": 681,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2105713954",
      "verified": true
    },
    {
      "title": "Corneal avascularity is due to soluble VEGF receptor-1",
      "journal": "Nature",
      "year": 2006,
      "citationCount": 674,
      "doi": "10.1038/nature05249",
      "sourceUrl": "https://doi.org/10.1038/nature05249",
      "verified": true
    },
    {
      "title": "Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1",
      "journal": "Science",
      "year": 2003,
      "citationCount": 669,
      "doi": "10.1126/science.1079562",
      "sourceUrl": "https://doi.org/10.1126/science.1079562",
      "verified": true
    },
    {
      "title": "Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2010,
      "citationCount": 657,
      "doi": "10.1073/pnas.1015855107",
      "sourceUrl": "https://doi.org/10.1073/pnas.1015855107",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:14.000Z",
  "openalexId": "https://openalex.org/A5101652233"
}